These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9859719)

  • 21. [Hypertension, obesity, ischemic heart disease].
    Heebøll-Nielsen NC
    Ugeskr Laeger; 1999 Dec; 161(50):6946. PubMed ID: 10643387
    [No Abstract]   [Full Text] [Related]  

  • 22. [Program for ischemic heart disease prevention].
    Katsumura T; Murase N
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():622-6. PubMed ID: 22519062
    [No Abstract]   [Full Text] [Related]  

  • 23. Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.
    Ritchie LD
    Br J Gen Pract; 2000 Sep; 50(458):693-5. PubMed ID: 11050781
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary heart disease. New guidelines for prevention.
    Harv Womens Health Watch; 1999 Aug; 6(12):2-3. PubMed ID: 10402323
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing risk for coronary heart disease: beyond Framingham.
    Cobb FR; Kraus WE; Root M; Allen JD
    Am Heart J; 2003 Oct; 146(4):572-80. PubMed ID: 14564309
    [No Abstract]   [Full Text] [Related]  

  • 26. Leisure time physical activity, competitive sports and ischemic heart disease by Börjesson M. et al.
    Franklin BA
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):133-6. PubMed ID: 16575265
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recording of risk factors and preventive pharmaceutical therapy among ischemic heart disease patients in family practice during the years 1993-1998].
    Goldfracht M; Alperin M; Alperin M; Hermoni D
    Harefuah; 2006 Apr; 145(4):266-8, 319. PubMed ID: 16642627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Wine--good for the heart?].
    Gyntelberg F
    Ugeskr Laeger; 1999 Dec; 161(50):6900. PubMed ID: 10643373
    [No Abstract]   [Full Text] [Related]  

  • 29. [Marine n-3 polyunsaturated fatty acids and coronary heart disease. Background and status].
    Schmidt EB
    Ugeskr Laeger; 2005 May; 167(18):1940-2. PubMed ID: 15929265
    [No Abstract]   [Full Text] [Related]  

  • 30. [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].
    Madsbad S; Larsen ML; Adeler HF; Kryhlmand M; Westergaard M
    Ugeskr Laeger; 2006 Apr; 168(17):1640-5. PubMed ID: 16674875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comments on the editorial "Ischemic heart disease and integrated rehabilitation].
    Ballegaard S
    Ugeskr Laeger; 2000 Sep; 162(37):4948-9. PubMed ID: 11002748
    [No Abstract]   [Full Text] [Related]  

  • 32. Coronary heart disease prevention: a general practice challenge.
    Fowler G
    J R Coll Gen Pract; 1988 Sep; 38(314):391-2. PubMed ID: 3076904
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
    Haghfelt T; Haghfelt A
    Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
    [No Abstract]   [Full Text] [Related]  

  • 35. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.
    Kedward J; Dakin L
    Br J Gen Pract; 2003 Sep; 53(494):684-9. PubMed ID: 15103875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease.
    Olsen J; Willaing I; Ladelund S; Jørgensen T; Gundgaard J; Sørensen J
    Int J Technol Assess Health Care; 2005; 21(2):194-202. PubMed ID: 15921059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical guidelines and practice: in search of the truth.
    Kereiakes DJ; Antman EM
    J Am Coll Cardiol; 2006 Sep; 48(6):1129-35; discussion 1136-8. PubMed ID: 16978994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotics in the prevention and treatment of coronary heart disease.
    Meier CR
    J Infect Dis; 2000 Jun; 181 Suppl 3():S558-62. PubMed ID: 10839758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of clopidogrel in the management of ischemic heart disease.
    Galla JM; Lincoff AM
    Curr Opin Cardiol; 2007 Jul; 22(4):273-9. PubMed ID: 17556877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.